Tao Lu
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Oncology top 10%
- Organic Chemistry top 5%
- Surgery top 10%
- Topics
- Computational Drug Discovery Methods (20 papers)Cancer-related Molecular Pathways (10 papers)Protein Degradation and Inhibitors (10 papers)
- Cited by
- HematologyAgingOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Tao Lu
111 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 128
- Molecular Biology 1.0k
- Biomedical Engineering 479
- Oncology 426
- Organic Chemistry 357
- Surgery 297
Countries citing papers authored by Tao Lu
This map shows the geographic impact of Tao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Lu more than expected).
Fields of papers citing papers by Tao Lu
This network shows the impact of papers produced by Tao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Lu. The network helps show where Tao Lu may publish in the future.
Co-authorship network of co-authors of Tao Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Tao Lu. A scholar is included among the top collaborators of Tao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Lu. Tao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 12 | |
| 12 | 16 | |
| 13 | 67 | |
| 14 | 22 | |
| 15 | 40 | |
| 16 | 7 | |
| 17 | 13 | |
| 18 | 18 | |
| 19 | 89 | |
| 20 | First detection of Tuala-like Hantanvirus from Eothenomys milelus in China. | 1 |
About Tao Lu
Tao Lu is a scholar working on Computational Theory and Mathematics, Oncology and Hepatology, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (20 papers), Cancer-related Molecular Pathways (10 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Hematology (207 citations), Aging (29 citations) and Oncology (426 citations). Tao Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yadong Chen, Xuanyong Liu, Congqin Ning, Paul K. Chu, Hongmei Li, Shuai Lü, Honglu Wu, Jin Wen, Ye Zhang and Rong Fu. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.